ZYMEWORKS INC. Total Contract Liability
ZYMEWORKS INC. (ZYME) had Total Contract Liability of $17.00 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-03-02
- 2025-12-31: Contract with Customer, Liability $17.00M.
- 2025-03-31: Contract with Customer, Liability $38.10M.
- 2024-12-31: Contract with Customer, Liability $40.20M.
- 2024-09-30: Contract with Customer, Liability $41.80M.
| Period end | Contract with Customer, Liability | Contract with Customer, Liability as first filed |
|---|---|---|
| 2025-12-31 | $17.00M 10-K · filed 2026-03-02 | |
| 2025-03-31 | $38.10M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $40.20M 10-K · filed 2026-03-02 | |
| 2024-09-30 | $41.80M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $38.46M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $36.38M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $36.60M 10-K · filed 2025-03-05 | $36.64M 10-K · filed 2024-03-06 |
| 2022-12-31 | $32.94M 10-K · filed 2024-03-06 | |
| 2021-12-31 | $32.94M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |